Retatrutide, from Soma Pharmaceuticals , is gaining increasing attention as a innovative treatment for obesity regulation. This unique drug combines the mechanism of a GLP-1 receptor activator and a GIP receptor activator , aiming to effectively promote metabolic improvements but also address underlying metabolic factors. Initial human studies h… Read More